Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited13.80706556349984.8292
Domestic EquitiesLupin Limited8.54623703676609.5880
Domestic EquitiesCipla Limited6.08463100000434.0000
Domestic EquitiesApollo Hospitals Enterprise Limited5.4094648795385.8449
Domestic EquitiesDivi's Laboratories Limited5.0547900808360.5394
Domestic EquitiesDr. Reddy's Laboratories Limited4.7843550030341.2551
Domestic EquitiesGland Pharma Limited4.07841700000290.9040
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited3.70451386868264.2330
Domestic EquitiesZydus Lifesciences Limited3.61032700632257.5188
Domestic EquitiesAbbott India Limited3.203086390228.4674
Domestic EquitiesVijaya Diagnostic Centre Limited3.09943161151221.0751
Domestic EquitiesAjanta Pharma Limited3.0073968214214.5030
Domestic EquitiesMedPlus Health Services Limited3.00593076603214.4085
Domestic EquitiesMankind Pharma Limited2.9860900794212.9837
Domestic EquitiesAurobindo Pharma Limited2.91221800800207.7223
Domestic EquitiesSanofi India Limited2.7547236008196.4896
Domestic EquitiesNarayana Hrudayalaya Limited2.70891501224193.2225
Domestic EquitiesAlkem Laboratories Limited2.5573377412182.4051
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited2.4982853907178.1890
Domestic EquitiesTorrent Pharmaceuticals Limited2.2353603364159.4420
Domestic EquitiesPfizer Limited1.8995318249135.4850
Domestic EquitiesFortis Healthcare Limited1.72152800000122.7940
Domestic EquitiesThyrocare Technologies Limited1.59671765838113.8877
Domestic EquitiesOrchid Pharma Limited1.093472303277.9898
Domestic EquitiesSyngene International Limited1.0867112479577.5152
Domestic EquitiesIndoco Remedies Limited0.8411183492459.9928
Domestic EquitiesConcord Biotech Limited0.587125119041.8759
Domestic EquitiesMetropolis Healthcare Limited0.532220885037.9637
Domestic EquitiesAstraZeneca Pharma India Limited0.47936407834.1875
Domestic EquitiesHealthcare Global Enterprises Limited0.205540043214.6578
Domestic EquitiesJubilant Pharmova Limited0.0655692814.6709
Total 96.1561 6858.6409
Cash & Cash Equivalents and Net AssetsTriparty Repo3.9201 279.6172
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0225 1.6032
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.0987 -7.0423
Total 3.8439 274.1781
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.